-
Who Develops Breast Cancer, When, and Why: Five Handholds for Reading Risk—and How to Use “Relative Risk” Correctly
-
Breast Cancer Is Not One Disease: The Big Picture and Its “Five Faces” in an Era of 1-in-8
-
Oncology Drug Approval News Flash: FDA Approves Nilotinib Orally Disintegrating Tablets (Cavhanza, Cycle Pharmaceuticals) for Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
-
The Last Mile to Deliver Breakthroughs Worldwide — How Equity, Liquid Biopsy, and AI Are Rewriting Cancer-Care Implementation
-
Will GLP-1 Change Cancer? — The State of Play on the New Battlefield of Metabolism x Oncology
